BIOMARIN PHARMACEUTICAL INC 4
4 · BIOMARIN PHARMACEUTICAL INC · Filed Mar 5, 2015
Insider Transaction Report
Form 4
LAPALME PIERRE
Director
Transactions
- Exercise/Conversion
Common Stock
2015-03-03$11.15/sh+10,000$111,500→ 40,150 total - Exercise/Conversion
Common Stock
2015-03-03$17.33/sh+10,000$173,300→ 50,150 total - Sale
Common Stock
2015-03-03$106.57/sh−20,000$2,131,400→ 30,150 total - Exercise/Conversion
Stock Option (right to buy Common Stock)
2015-03-03−10,000→ 0 totalExercise: $11.15From: 2006-07-27Exp: 2016-01-26→ Common Stock (10,000 underlying) - Exercise/Conversion
Stock Option (right to buy Common Stock)
2015-03-03−10,000→ 12,500 totalExercise: $17.33From: 2007-12-07Exp: 2017-06-06→ Common Stock (10,000 underlying)
Holdings
- 1,500(indirect: By Spouse)
Common Stock
Footnotes (4)
- [F1]The price in column 4 is an average weighted price. The price actually received ranged from $106.20 to 106.895. The reporting person shall provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the amount of shares sold at each price within the range.
- [F2]Original option grant vests 6/48ths on July 27, 2006, and 1/48th on the 27th of each month thereafter.
- [F3]Reflects the number of stock options that remain outstanding from this specific stock option grant following the reported transaction.
- [F4]Original option grant vests 6/48ths on December 7, 2007, and 1/48th on the 7th of each month thereafter.